These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1354 related items for PubMed ID: 28453491

  • 41. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW, Ogino K, Shimabuku A, Taki T, Nakashima H, Ishihara T, Kitamoto T.
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [Abstract] [Full Text] [Related]

  • 42. A critical analysis of the 'amyloid cascade hypothesis'.
    Armstrong RA.
    Folia Neuropathol; 2014 Jun; 52(3):211-25. PubMed ID: 25310732
    [Abstract] [Full Text] [Related]

  • 43. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S.
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [Abstract] [Full Text] [Related]

  • 44. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J, Bobinski M, Tarnawski M, Dziewiatkowski J, Popovitch E, Miller DC, Wisniewski T, Golomb J, de Leon MJ, Reisberg B.
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [Abstract] [Full Text] [Related]

  • 45. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
    Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):10032-7. PubMed ID: 12888622
    [Abstract] [Full Text] [Related]

  • 46. Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.
    Hunter S, Minett T, Polvikoski T, Mukaetova-Ladinska E, Brayne C, Cambridge City over-75s Cohort Collaboration.
    Alzheimers Res Ther; 2015 Aug 28; 7(1):57. PubMed ID: 26315613
    [Abstract] [Full Text] [Related]

  • 47. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ, Jones G, Cranston A, Gardner H, Kanaan NM, Platt B.
    Acta Neuropathol; 2016 Dec 28; 132(6):875-895. PubMed ID: 27770234
    [Abstract] [Full Text] [Related]

  • 48. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
    Götz J, Chen F, van Dorpe J, Nitsch RM.
    Science; 2001 Aug 24; 293(5534):1491-5. PubMed ID: 11520988
    [Abstract] [Full Text] [Related]

  • 49. Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease.
    Wee M, Chegini F, Power JHT, Majd S.
    Curr Alzheimer Res; 2018 Aug 24; 15(10):928-937. PubMed ID: 29895248
    [Abstract] [Full Text] [Related]

  • 50. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E, Azizeh BY, Lott IT, Tenner AJ, Cotman CW, Cribbs DH.
    Neurobiol Dis; 2001 Apr 24; 8(2):252-65. PubMed ID: 11300721
    [Abstract] [Full Text] [Related]

  • 51. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S, Yamazaki T, Makioka K, Fujita Y, Ikeda M, Takatama M, Okamoto K, Yokoo H, Ikeda Y.
    Neuropathology; 2016 Aug 24; 36(4):333-45. PubMed ID: 26685795
    [Abstract] [Full Text] [Related]

  • 52. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K, Kobayashi K, Kitamura T, Sudo S, Koshino Y.
    Psychiatry Clin Neurosci; 2007 Apr 24; 61(2):159-67. PubMed ID: 17362433
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.
    Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A.
    Mol Chem Neuropathol; 1996 Apr 24; 27(3):225-47. PubMed ID: 9147410
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE, Sekhar N, Rajamma RG, Marathakam A, Al Mamun A, Uddin MS, Mathew B.
    Curr Protein Pept Sci; 2020 Apr 24; 21(12):1164-1173. PubMed ID: 32957903
    [Abstract] [Full Text] [Related]

  • 58. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
    Savioz A, Giannakopoulos P, Herrmann FR, Klein WL, Kövari E, Bouras C, Giacobini E.
    Neurodegener Dis; 2016 Apr 24; 16(5-6):398-406. PubMed ID: 27400224
    [Abstract] [Full Text] [Related]

  • 59. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.
    Guimarães TR, Swanson E, Kofler J, Thathiah A.
    Neuropathol Appl Neurobiol; 2021 Dec 24; 47(7):942-957. PubMed ID: 34164834
    [Abstract] [Full Text] [Related]

  • 60. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.
    Braak H, Zetterberg H, Del Tredici K, Blennow K.
    Acta Neuropathol; 2013 Nov 24; 126(5):631-41. PubMed ID: 23756600
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.